Psoriasis

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

A Clinical Trial of TQH2929 Injection in Patients With Acute Flare-up of Generalized Pustular Psoriasis

Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis

Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study

Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial

A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study

Safety and Efficacy of RAP-103 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects

A Phase 2 Study of HB0017 in Psoriasis Patients

A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis

A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

A Herbal Compound for Psoriasis

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis

Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical Trial

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis

Treatment of Moderate to Severe Plaque Psoriasis

To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

Topical SGX302 for Mild-to-Moderate Psoriasis

Tofacitinib for Immune Skin Conditions in Down Syndrome

Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

High Dose Risankizumab for Psoriasis

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Initial Dosing of BI 655130 in Palmoplantar Pustulosis Patients

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis

A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

Rimegepant in Moderate Plaque-type Psoriasis

Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis

Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis

Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study).

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis

Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis

Safety and Efficacy of CD10367 in Psoriasis Vulgaris

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Study to Assess the Efficacy and Safety of Orismilast in Psoriasis

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Efficacy of Roflumilast in the Treatment of Psoriasis

A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis

A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)

Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3)

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis

Safety and Efficacy of Secukinumab in Mild Psoriasis

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis

A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

AGN-242428 in the Treatment of Plaque Psoriasis

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Psoriasis-Arthritis & Bone Program

A Trial of a Botanical Drug (EISO) for Treatment of Mild-to-Moderate Plaque Psoriasis

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Efficacy and Safety of TC Cream In Treating Patients With Psoriasis Vulgaris

Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic Skin

A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris

Study to Evaluate Safety and Efficacy of Oral MP1032 in Psoriasis Patients

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients

Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Treatment

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

A Trial of SHR-1139 in Healthy Volunteers

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Maximal Usage Pharmacokinetics and Safety Study of ARQ-154 Foam 0.3% in Pediatric Participants With Scalp and Body Psoriasis

Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage

Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers

A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.

Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment

Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis

A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®)

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris

A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis

Phase I Randomized, Open-label, Parallel-controlled, Pharmacokinetic and Safety Study of BR201 Injection Versus Cosentyx in Healthy Male Subjects

A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

A Clinical Study of TQH2929 in Healthy Adult Subjects

Bioequivalence Test of Hemay005 Tablets

A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis

A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

A Study of AK111 in Healthy Subjects

An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A

Dermatopharmacokinetic Trial of LEO 80185 Gel

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.

A Study to Assess S011806 (DC-806 or LY4100504) in Healthy Adult Participants and Participants With Chronic Plaque Psoriasis

This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357

A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis.

Safety and Tolerability Study of MSC Exosome Ointment

Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis

A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

Ethoximod Pharmacokinetics In Healthy Subjects

Pharmacokinetic, Safety and Immunogenicity Study of CMAB015 and Cosentyx in Healthy Volunteers

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

A Study of LY3471851 in Participants With Psoriasis

A Study of Mirikizumab in Participants With Plaque Psoriasis

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

HB0034 in Patients With Generalized Pustular Psoriasis (GPP)

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Plexin B2 Gene Expression and Polymorphisms in Psoriasis

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10374 in Healthy Subjects

Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects

Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis

Phase I Study of GN-037 Cream for Psoriasis

A Study of DLX105-DMP in Subjects With Plaque Psoriasis

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

A Phase 1 Study to Assess Single and Multiple Ascending Doses of PBI-100 Topical Cream

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

A Study of LY3361237 in Participants With Psoriasis

An Open-Label Study to Assess Safety

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

A Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab)

Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis

Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.

A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis

Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque Psoriasis

A Multiple Dose Study of BAY1834845 in Healthy Male Subjects and in Patients With Psoriasis

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis

Study to Evaluate the Safety and Antipsoriatic Efficacy of BOS-475 in a Psoriasis Plaque Test

A Study of Ixekizumab in Chinese Participants With Psoriasis Vulgaris

Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Efficacy of Low Dose Naltrexone in Psoriasis

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

A Study of LY3041658 in Participants With Skin Diseases

Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers

A Study of Ixekizumab in Participants With Plaque Psoriasis

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

A Study Assessing the PK, PD, Safety, and Tolerability of SB414 in Psoriasis

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

A Study of SHR-1314 in Healthy Subjects

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis

This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis

Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis

Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque Psoriasis

Vasoconstriction Trial With LEO 90100 Aerosol Foam

LEO 32731 - A Phase I Study in Healthy Subjects

A Phase I Study With LEO 32731 and Midazolam in Healthy Male Subjects

Bioavailability of AZD0284 and IV Microtracer Study

BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008

Single Ascending Dose Study of PRX003 in Healthy Subjects

Proactive TDM Versus Standard Use of Biologics in Psoriasis

A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares

Methotrexate Versus Apremilast for Pruritus in Psoriasis

A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis

Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Topical Diacerein in Psoriasis Vulgaris

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Bimekizumab in Plaque Psoriasis

Risankizumab Long-term Remission Study

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

Local Methotrexate Injections for the Treatment of Nail Psoriasis

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Multi-Center PAMPA Study

Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Correction of Psoriatic T Cell Signatures by Deucravacitinib

Botox Versus Tacrolimus in Psoriasis Vulgaris

Guselkumab Immunogenetics

Immune Spatial Features of Guselkumab Cutaneous Response

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Taltz in Combination With Enstilar for Psoriasis

Duobrii in Combination With Biologics

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

MIcrovascular dysfuNction In Moderate-severe Psoriasis

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis (Phase IV)

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life

A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis

A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck Region

Brain Changes in Psoriasis After Secukinumab Treatment

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis

Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin Lesions

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Dose Tapering Study of Adalimumab in Psoriasis

Effects of Tildrakizumab on Epigenetic Age

Effect of Semaglutide on the Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

Predicting Inflammatory Skin Disease Response to IL-23 Blockade

Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis

Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Topical Psoriasis Study for Patients Receiving Biologic Therapy

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Vtama in Psoriasis Patients Being Treated With Biologics.

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis

Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis

Efficacy and Safety of Apremilast in Psoriasis

Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis

Outcome of Treatment With Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis at Tertiary Care Hospital.

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated

Vascular Inflammation in Psoriasis - Apremilast

Proton Pump Inhibitors Use in Patients With Psoriasis

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin

Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE

Pain Outcomes Following Intralesional Corticosteroid Injections

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Immunologic Response to Secukinumab in Plaque Psoriasis

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Evaluating Treatment Resistant Dermatitis TaroIIR

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis

A Phase 4 Clinical Study of Brodalumab

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Apremilast in Palmo-Plantar Psoriasis

A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

Enstilar in Combination With Biologic Agents

Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.